Preoperative immunosuppression: its relationship with high morbidity and mortality in patients receiving thoracic esophagectomy.
The operative procedure for thoracic esophageal cancer, including thoracotomy, laparotomy, and three-field lymph node dissection, is a particularly stressful surgery that is characterized by high morbidity and mortality. The aim of this study was to evaluate the immunologic and nutritional states of patients to determine possible predictive factors of morbidity and mortality in patients receiving thoracic esophagectomy. Patients receiving thoracic esophagectomy were retrospectively divided into two groups. One group had postoperative infectious complications (group C+, n = 27), and the other had no complications (group C-, n = 76). They were treated with total parenteral nutrition or enteral nutrition providing 35-40 kcal. kg(-1). d(-1) of energy and 1.3-1.5 kcal. kg(-1). d(-1) of amino acids throughout the study period. The phytohemagglutinin (PHA)- and concanavalin A (Con A)-induced proliferation of peripheral blood mononuclear cells (PBMC) from the patients were measured before and at days 7 and 21 after the operation. Serum albumin, prealbumin, transferrin, the retinol binding protein, and the C-reactive protein were also evaluated. Three patients out of 27 in group C+ died because of severe infectious complications, whereas none of patients was fatal in group C-. PHA- and Con A-induced proliferation of PBMC was significantly low before the operation and remained suppressed on the 21st postoperative day in group C+. No significant difference was observed in nutritional status during the perioperative days between the two groups. Our results indicate that esophageal cancer patients with preoperative suppression of the cell-mediated immunity can be identified as a higher risk population in the postoperative period. When adequate nutrition is received, however, the correlation between nutritional status and mortality disappears.
Takagi
K
K
First Department of Surgery, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan 260-0856.
Yamamori
H
H
Morishima
Y
Y
Toyoda
Y
Y
Nakajima
N
N
Tashiro
T
T
D001798:Blood Proteins / Q000032:analysis; D003208:Concanavalin A / Q000032:analysis; D004750:Enteral Nutrition; D004938:Esophageal Neoplasms / Q000276:immunology / Q000601:surgery*; D016629:Esophagectomy; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D010289:Parenteral Nutrition, Total; D019990:Perioperative Care; D010835:Phytohemagglutinins / Q000032:analysis; D011300:Preoperative Care; D012189:Retrospective Studies; D018805:Sepsis / Q000150:complications; D013312:Stress, Physiological / Q000276:immunology*
D001798:Blood Proteins; D010835:Phytohemagglutinins; D003208:Concanavalin A